Persistent detection of varicella-zoster virus DNA in a previously healthy child after severe chickenpox

Journal of Clinical Microbiology

Volumn 43, Issue 11, 2005, Pages 5614-5621

  Vossen, Mireille T M ^a,b   Gent, Mi Ran ^a,b   Peters, Karla M C ^b   Wertheim Van Dillen, Pauline M E ^b   Dolman, Koert M ^a   Van Breda, Alex ^b   Van Lier, René A W ^b   Kuijpers, Taco W ^a  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; VIRUS DNA;

ARTICLE; B LYMPHOCYTE; CASE REPORT; CELLULAR IMMUNITY; CHICKENPOX; CHILD; CLEARANCE; CONVALESCENCE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOCOMPETENCE; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; MALE; NATURAL KILLER CELL; PERSISTENT VIRUS DETECTION; PRIORITY JOURNAL; RASH; VARICELLA ZOSTER VIRUS; VIRUS DETECTION; VIRUS LOAD;

B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHICKENPOX; CHILD, PRESCHOOL; DNA, VIRAL; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNOCOMPETENCE; KILLER CELLS, NATURAL; MALE; VIRAL LOAD;

DNA VIRUSES; HUMAN HERPESVIRUS 3; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 27744513298     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.11.5614-5621.2005     Document Type: Article

References (53)

1. Arvin, A. M., C. M. Koropchak, B. R. Williams, F. C. Grumet, and S. K. Foung. 1986. Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection. J. Infect. Dis. 154:422-429.
2. Arvin, A. M., J. H. Kushner, S. Feldman, R. L. Baehner, D. Hammond, and T. C. Merigan. 1982. Human leukocyte interferon for the treatment of varicella in children with cancer. N. Engl. J. Med. 306:761-765.
3. Biron, C. A., K. S. Byron, and J. L. Sullivan. 1989. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320:1731-1735.
4. Boom, R., C. Sol, J. Weel, Y. Gerrits, M. de Boer, and P. Wertheim-van Dillen. 1999. A highly sensitive assay for detection and quantitation of human cytomegalovirus DNA in serum and plasma by PCR and electrochemiluminescence. J. Clin. Microbiol. 37:1489-1497.
5. Breuer, J. 2002. Studies on shingles, is the virus ordinary chickenpox virus? Rev. Med. Virol. 12:5-11.
6. Cantoni, C., C. Bottino, M. Vitale, A. Pessino, R. Augugliaro, A. Malaspina, S. Parolini, L. Moretta, A. Moretta, and R. Biassoni. 1999. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J. Exp. Med. 189:787-796.
7. Cheatham, W. J., T. F. Dolan, Jr., J. C. Dower, and T. H. Weller. 1956. Varicella: report of two fatal cases with necropsy, virus isolation, and serologic studies. Am. J. Pathol. 32:1015-1035.
8. Cohrs, R. J., M. Barbour, and D. H. Gilden. 1996. Varicella-zoster virus (VZV) transcription during latency in human ganglia: detection of transcripts mapping to genes 21, 29, 62, and 63 in a cDNA library enriched for VZV RNA. J. Virol. 70:2789-2796.
9. Cohrs, R. J., D. H. Gilden, P. R. Kinchington, E. Grinfeld, and P. G. Kennedy. 2003. Varicella-zoster virus gene 66 transcription and translation in latently infected human ganglia. J. Virol. 77:6660-6665.
10. Cohrs, R. J., J. Randall, J. Smith, D. H. Gilden, C. Dabrowski, H. van der Keyl, and R. Tal-Singer. 2000. Analysis of individual human trigeminal ganglia for latent herpes simplex virus type 1 and varicella-zoster virus nucleic acids using real-time PCR. J. Virol. 74:11464-11471.
11. Cooper, E. C., L. K. Vujcic, and G. V. Quinnan, Jr. 1988. Varicella-zoster virus-specific HLA-restricted cytotoxicity of normal immune adult lymphocytes after in vitro stimulation. J. Infect. Dis. 158:780-788.
12. Croen, K. D., J. M. Ostrove, L. J. Dragovic, and S. E. Straus. 1988. Patterns of gene expression and sites of latency in human nerve ganglia are different for varicella-zoster and herpes simplex viruses. Proc. Natl. Acad. Sci. USA 85:9773-9777.
13. Davison, A. J., and J. E. Scott. 1986. The complete DNA sequence of varicella-zoster virus. J. Gen. Virol. 67:1759-1816.
14. De Boer, R. J., D. Homann, and A. S. Perelson. 2003. Different dynamics of CD4+ and CD8+ T cell responses during and after acute lymphocytic choriomeningitis virus infection. J. Immunol. 171:3928-3935.
15. de Jong, M. D., J. F. Weel, T. Schuurman, P. M. Wertheim-van Dillen, and R. Boom. 2000. Quantitation of varicella-zoster virus DNA in whole blood, plasma, and serum by PCR and electrochemiluminescence. J. Clin. Microbiol. 38:2568-2573.
16. Diaz, P. S., S. Smith, E. Hunter, and A. M. Arvin. 1989. T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine. J. Immunol. 142:636-641.
17. Furuta, Y., S. Fukuda, S. Suzuki, T. Takasu, Y. Inuyama, and K. Nagashima. 1997. Detection of varicella-zoster virus DNA in patients with acute peripheral facial palsy by the polymerase chain reaction, and its use for early diagnosis of zoster sine herpete. J. Med. Virol. 52:316-319.
18. Gilden, D. H., B. K. Kleinschmidt-DeMasters, J. J. LaGuardia, R. Mahalingam, and R. J. Cohrs. 2000. Neurologic complications of the reactivation of varicella-zoster virus. N. Engl. J. Med. 342:635-645.
19. Gilden, D. H., Y. Rozenman, R. Murray, M. Devlin, and A. Vafai. 1987. Detection of varicella-zoster virus nucleic acid in neurons of normal human thoracic ganglia. Ann. Neurol. 22:377-380.
20. Hamann, D., P. A. Baars, M. H. Rep, B. Hooibrink, S. R. Kerkhof-Garde, M. R. Klein, and R. A. van Lier. 1997. Phenotypic and functional separation of memory and effector human CD8+ T cells. J. Exp. Med. 186:1407-1418.
21. Hayward, A. R., O. Pontesilli, M. Herberger, M. Laszlo, and M. Levin. 1986. Specific lysis of varicella zoster virus-infected B lymphoblasts by human T cells. J. Virol. 58:179-184.
22. Hickling, J. K., L. K. Borysiewicz, and J. G. Sissons. 1987. Varicella-zoster virus-specific cytotoxic T lymphocytes (Tc): detection and frequency analysis of HLA class I-restricted Tc in human peripheral blood. J. Virol. 61:3463-3469.
23. Homann, D., L. Teyton, and M. B. Oldstone. 2001. Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory. Nat. Med. 7:913-919.
24. Hope-Simpson, R. E. 1965. The nature of herpes zoster: a long-term study and a new hypothesis. Proc. R. Soc. Med. 58:9-20.
25. Houchins, J. P., L. L. Lanier, E. C. Niemi, J. H. Phillips, and J. C. Ryan. 1997. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. J. Immunol. 158:3603-3609.
26. + human T-cell clones. J. Virol. 66:2664-2669.
27. Ito, Y., H. Kimura, S. Hara, S. Kido, T. Ozaki, Y. Nishiyama, and T. Morishima. 2001. Investigation of varicella-zoster virus DNA in lymphocyte subpopulations by quantitative PCR assay. Microbiol. Immunol. 45:267-269.
28. Kennedy, P. G., E. Grinfeld, and J. E. Bell. 2000. Varicella-zoster virus gene expression in latently infected and explanted human ganglia. J. Virol. 74:11893-11898.
29. Kennedy, P. G., E. Grinfeld, and J. W. Gow. 1999. Latent varicella-zoster virus in human dorsal root ganglia. Virology 258:451-454.
30. Kimura, H., S. Kido, T. Ozaki, N. Tanaka, Y. Ito, R. K. Williams, and T. Morishima. 2000. Comparison of quantitations of viral load in varicella and zoster. J. Clin. Microbiol. 38:2447-2449.
31. Kinchington, P. R. 1999. Latency of varicella zoster virus; a persistently perplexing state. Frontiers Biosci. 4:D200-D211.
32. Kinchington, P. R., K. Fite, and S. E. Turse. 2000. Nuclear accumulation of IE62, the varicella-zoster virus (VZV) major transcriptional regulatory protein, is inhibited by phosphorylation mediated by the VZV open reading frame 66 protein kinase. J. Virol. 74:2265-2277.
33. Kuijpers, T. W., M. T. Vossen, M. R. Gent, J. C. Davin, M. T. Roos, P. M. Wertheim-van Dillen, J. F. Weel, P. A. Baars, and R. A. van Lier. 2003. Frequencies of circulating cytolytic, CD45RA+CD27-, CD8+ T lymphocytes depend on infection with CMV. J. Immunol. 170:4342-4348.
34. Lacey, S. F., T. Suzutani, K. L. Powell, D. J. Purifoy, and R. W. Honess. 1991. Analysis of mutations in the thymidine kinase genes of drug-resistant varicella-zoster virus populations using the polymerase chain reaction. J. Gen. Virol. 72:623-630.
35. LaGuardia, J. J., R. J. Cohrs, and D. H. Gilden. 1999. Prevalence of varicella-zoster virus DNA in dissociated human trigeminal ganglion neurons and nonneuronal cells. J. Virol. 73:8571-8577.
36. Levin, M. J., G. Y. Cai, M. D. Manchak, and L. I. Pizer. 2003. Varicellazoster virus DNA in cells isolated from human trigeminal ganglia. J. Virol. 77:6979-6987.
37. Levin, M. J., K. M. Dahl, A. Weinberg, R. Giller, A. Patel, and P. R. Krause. 2003. Development of resistance to acyclovir during chronic infection with the Oka vaccine strain of varicella-zoster virus, in an immunosuppressed child. J. Infect. Dis. 188:954-959.
38. Lungu, O., C. A. Panagiotidis, P. W. Annunziato, A. A. Gershon, and S. J. Silverstein. 1998. Aberrant intracellular localization of varicella-zoster virus regulatory proteins during latency. Proc. Natl. Acad. Sci. USA 95:7080-7085.
39. Meier, J. L., R. P. Holman, K. D. Croen, J. E. Smialek, and S. E. Straus. 1993. Varicella-zoster virus transcription in human trigeminal ganglia. Virology 193:193-200.
40. Morita, Y., Y. Osaki, Y. Doi, B. Forghani, and D. H. Gilden. 2003. Chronic active VZV infection manifesting as zoster sine herpete, zoster paresis and myelopathy. J. Neurol. Sci. 212:7-9.
41. Polic, B., D. Kunkel, A. Scheffold, and K. Rajewsky. 2001. How alpha beta T cells deal with induced TCR alpha ablation. Proc. Natl. Acad. Sci. USA 98:8744-8749.
42. Saint-Leger, E., E. Caumes, G. Breton, D. Douard, P. Saiag, J. M. Huraux, F. Bricaire, H. Agut, and A. M. Fillet. 2001. Clinical and virologic characterization of acyclovir-resistant varicella-zoster viruses isolated from 11 patients with acquired immunodeficiency syndrome. Clin. Infect. Dis. 33:2061-2067.
43. Sato, H., L. Pesnicak, and J. I. Cohen. 2003. Varicella-zoster virus ORF47 protein kinase, which is required for replication in human T cells, and ORF66 protein kinase, which is expressed during latency, are dispensable for establishment of latency. J. Virol. 77:11180-11185.
44. Sharp, M., K. Terada, A. Wilson, S. Nader, P. E. Kinchington, W. T. Ruyechan, J. Hay, and A. M. Arvin. 1992. Kinetics and viral protein specificity of the cytotoxic T lymphocyte response in healthy adults immunized with live attenuated varicella vaccine. J. Infect. Dis. 165:852-858.
45. Straus, S. E., W. Reinhold, H. A. Smith, W. T. Ruyechan, D. K. Henderson, R. M. Blaese, and J. Hay. 1984. Endonuclease analysis of viral DNA from varicella and subsequent zoster infections in the same patient. N. Engl. J. Med. 311:1362-1364.
46. van Lier, R. A., I. J. ten Berge, and L. E. Gamadia. 2003. Human CD8(+) T-cell differentiation in response to viruses. Nat. Rev. Immunol. 3:931-939.
47. Vazquez, M., P. S. LaRussa, A. A. Gershon, S. P. Steinberg, K. Freudigman, and E. D. Shapiro. 2001. The effectiveness of the varicella vaccine in clinical practice. N. Engl. J. Med. 344:955-960.
48. von Seidlein, L., S. G. Gillette, Y. Bryson, T. Frederick, L. Mascola, J. Church, P. Brunell, A. Kovacs, A. Deveikis, and M. Keller. 1996. Frequent recurrence and persistence of varicella-zoster virus infections in children infected with human immunodeficiency virus type 1. J. Pediatr. 128:52-57.
49. Vossen, M. T., M. H. Biezeveld, M. D. de Jong, M. R. Gent, P. A. Baars, I. A. von Rosenstiel, R. A. van Lier, and T. W. Kuijpers. 2005. Absence of circulating natural killer and primed CD8+ cells in life-threatening varicella. J. Infect. Dis. 191:198-206.
50. Vossen, M. T., M. R. Gent, J. F. Weel, M. D. de Jong, R. A. van Lier, and T. W. Kuijpers. 2004. Development of virus-specific CD4+ T cells on reexposure to varicella-zoster virus. J. Infect. Dis. 190:72-82.
51. Weller, T. H. 1983. Varicella and herpes zoster. Changing concepts of the natural history, control, and importance of a not-so-benign virus. N. Engl. J. Med. 309:1362-1368.
52. White, T. M., R. Mahalingam, V. Traina-Dorge, and D. H. Gilden. 2002. Persistence of simian varicella virus DNA in CD4(+) and CD8(+) blood mononuclear cells for years after intratracheal inoculation of African green monkeys. Virology 303:192-198.
53. Zampogna, J. C., and F. P. Flowers. 2001. Persistent verrucous varicella as the initial manifestation of HIV infection. J. Am. Acad. Dermatol. 44:391-394.